The effects of low-dose testosterone treatment on lipid metabolism, clotting factors and ultrasonographic ovarian morphology in women

Clinical Endocrinology

Volumn 49, Issue 2, 1998, Pages 173-178

  Buckler, H M ^a   McElhone, K ^a   Durrington, P N ^b   Mackness, M I ^b   Ludlam, C A ^c   Wu, F C W ^b  

^a HOPE HOSPITAL   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^c ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; BETA THROMBOGLOBULIN; BLOOD CLOTTING FACTOR; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; FIBRINOGEN; HEMOSTATIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PLASMINOGEN ACTIVATOR INHIBITOR; PROTEIN C; PROTEIN S; PROTHROMBIN; TESTOSTERONE; TISSUE PLASMINOGEN ACTIVATOR; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG IMPLANT; ECHOGRAPHY; FEMALE; HUMAN; LIPID METABOLISM; MORPHOLOGY; OVARY; OVARY POLYCYSTIC DISEASE; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; PROTHROMBIN TIME; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; APOLIPOPROTEIN A-I; BLOOD COAGULATION FACTORS; CHOLESTEROL, HDL; CHOLESTEROL, VLDL; DRUG ADMINISTRATION SCHEDULE; DRUG IMPLANTS; FEMALE; HUMANS; LIPIDS; OVARY; PREMENSTRUAL SYNDROME; TESTOSTERONE;

EID: 0031855508     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1998.00525.x     Document Type: Article

References (48)

1. Adams, J., Polson, D.W., Abdulwahid, N., Morris, D.V., Frank, S., Mason, H.D., Tucker, M., Price, J. & Jacobs, H.S. (1985) Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotrophin releasing hormone. Lancet, 2, 1375-1378.
2. Albers, J.J., Taggart, H.M., Applebown-Bowden, D., Haffner, S.M., Chestnut, C.H. & Hazard, W.R. (1984) Reduction of lecithin cholesterol acyltransferase, apolipoprotein D and the lipoprotein-a lipoprotein with the anabolic steroid Stanazolol. Biochemical Biophysical Acta, 795, 293-296.
3. Anderson, R.A., Ludlam, C.A. & Wu, F.C.W. (1995) Haemostatic effects of supraphysiological levels of testosterone in normal men. Thrombosis and Haemostasis, 74, 693-697.
4. Bagatell, C.J. & Bremner, W.J. (1996) Androgens in men uses and abuses. New England Journal of Medicine, 334, 707-714.
5. Buckler, H.M., Sheffield, B., Misra, R. & Anderson, D.C. (1989) The use of low dose testosterone implants in premenstrual syndrome. Journal of Endocrinology, 123, 34.
6. Burger, H., Hailes, J., Menelaus, M., Nelson, J., Hudson, B. & Balaz, S.N. (1984) The management of persistent menopausal symptoms with oestradiol testosterone implants. Clinical lipid and hormone results. Maturitus, 6, 351-358.
7. Burger, H., Hailes, J., Nelson, J. & Menelaus, M. (1987) Effects of combined implants of oestradiol and testosterone on libido in post menopausal women. British Medical Journal, 294, 936-937.
8. Channon, K.M., Clegg, R.J., Bhatnagar, D., Ishola, M., Arrol, S. & Durrington, P.N. (1990) Investigation of lipid transfer in human serum leading to the development of an isotopic method for the determination of endogenous cholesterol esterification and transfer. Atherosclerosis, 80, 217-276.
9. Corker, C.S. & Davidson, D.W. (1978) Radioimmunoassay of testosterone in various biological fluids without chromotography. Journal of Steroid Biochemistry, 9, 373-374.
10. Crook, D., Fidhu, M., Seed, M., O'Donnell, M. & Stevenson, J.C. (1992) Lipoprotein(a) levels in women given Danazol and impeded androgen. Atherosclerosis, 92, 41-47.
11. Davis, S.R., McLoud, P., Strauss, B.J.G. & Burger, H. (1995) Testosterone enhances oestradiol's effect on postmenopausal bone density and sexuality. Maturitus, 21, 227-236.
12. Dewis, P., Newman, M., Ratcliffe, W.A. & Anderson, D.C. (1986) Does testosterone affect the normal menstrual cycle. Clinical Endocrinology, 24, 515-521.
13. Farish, E., Fletcher, C.D., Hart, D.M., Alazzwi, F., Abdalla, H.I. & Grey, C.E. (1984) The effects of hormone implants on serum lipoproteins and steroid hormones in bilateral oophorectomised women. Acta Endocrinology, 106, 116-120.
14. Farish, E., Rolton, H.A., Barnes, J.F. & Hart, D.M. (1991) Lipoprotein(a) concentrations in postmenopausal women taking norethisterone. British Medical Journal, 303, 694.
15. Ferenchick, G.S. (1990) Are androgenic steroids thrombogenic? New England Journal of Medicine, 322, 476.
16. Franks, S. (1995) Medical progress: Polycystic ovarian syndrome. New England Journal of Medicine, 333, 853-861.
17. Furman, R.H., Alaupobic, P. & Howard, R.P. (1967) Hormones and lipoproteins. Progress in Biochemical Pharmacology, 2, 215-258.
18. Gambrell, R.D. Jr. & & Teran, A.Z. (1991) Changes in lipids and lipoproteins with long term oestrogen deficiency and hormone replacement therapy. American Journal of Obstetrics and Gynecology, 165, 307-315.
19. Greer, I.A., Greaves, M., Madhock, R., McLoughlin, K., Porter, N., Lowe, G.D.O., Preston, F.E. & Forbes, C.D. (1985) Effect of stanazolol on factors 8 and 9 and serum aminotransferases in haemophilia. Thrombosis and Haemostasis, 53, 386-389.
20. Haffner, S.M., Katz, M.S., Stern, M.P. & Done, J.F. (1989) Association of decreased sex hormone by d-globulin and cardiovascular risk factors. Arteriosclerosis, 9, 136-143.
21. Heiss, G., Tamir, I., Davies, C.E., Tyrolen, H.S., Rifkand, B.M. & Schonfeld, Y. (1980) Lipoprotein cholesterol distributions in selected North American populations. The Lipid Research Clinics Program Prevalence Studv Circulation, 61, 302-315.
22. Hickok, L.R., Toomey, C., & Speroff, L. (1993) A comparison of esterified estrogens with and without methyl testosterone: effects of endometrial histology ans serum lipoproteins in post-menopausal women. Obstetrics and Gynecology, 82, 919-924.
23. Kaplan, H.S. & Owett, T. (1993) The female androgen deficiency syndrome. Journal of Sexual Marital Therapy, 19, 3-24.
24. Kluft, C., Preston, F.E., Malia, R.G., Bertina, R.M., Wijngaards, G., Greaves, N., Berheijen, J.H. & Dooijewaard, G. (1984) Stanazolol induced changes in fibrinolysis and coagulation in healthy adults. Thrombosis and Haemostasis, 51, 157-164.
25. Lobo, R.A. (1991) Effects of hormonal replacement on lipids and lipoproteins in postmenopausal women. Journal of Clinical Endocrinology and Metabolism, 73, 925-930.
26. Longcope, C. (1986) Adrenal and gonadal androgen secretion in normal females. Clinical Endocrinology and Metabolism, 15, 213-228.
27. Lowe, G.D.O., Thompson, J.E., Reavey, M.M., Forbes, C.D. & Prentice, C.R.M. (1979) Mesterolone: Thrombosis during treatment and a study of its prothrombotic effects. British Journal of Clinical Pharmacology, 7, 107-109.
28. Mackness, M.I. & Durrington, P.N. (1991) Lipoprotein analysis for clinical studies. In: Lipoprotein Analysis. A Practical Approach (eds. C.A. Converse & E.R. Skinner), pp. 1-42. Oxford University Press, Oxford.
29. Meilahn, E.N., Kuller, L.A., Matthews, K.A. & Kiss, J.E. (1992) Haemastatic factors according to menopausal status and use of hormone replacement therapy. The Annals of Epidemiology, 2, 445-455.
30. Meilahn, E.N., Cauley, J.A., Tracey, R.P., Macey, E.O., Gutay, J.P. & Kuller, L.H. (1996) Association of sex hormones in adiposity with plasma levels of fibrinogen and PAI-1 in postmenopausal women. American Journal of Epidemiology, 143, 159-156.
31. Mirand, E.A., Gordon, A.W. & Wenwick, J. (1965) Mechanism of testosterone action in iatropoeisis. Nature, 206, 270.
32. Olofsson, B.O., Dahlen, G. & Nilsson, T.K. (1989) Evidence for increased levels of plasminogen activator inhibitor and tissue plasminogen activator in plasma of patients with angiographically verified coronary artery disease. European Heart Journal, 10, 77-82.
33. Raisz, L.G., Wiita, B., Artis, A., Bowen, A., Schwartz, S., Trahiotis, M., Shoukri, K. & Smith, J. (1996) Comparison of the effects of oestrogen alone and oestrogen plus androgen on biochemical markers of bone formation and resorption in menopausal women. Journal of Clinical Endocrinology and Metabolism, 81, 37-13.
34. Robinson, R.J. & Wise, F. (1993) Misuse of anabolic drugs. British Medical Journal, 306, 61.
35. Seed, M. & Cook, D. (1994) Hormonal replacement therapies, cardiovascular disease and plasma lipoproteins. Current Opinion in Lipidology, 5, 48-58.
36. Semmens, J., Rouse, I., Beilen, L.J. & Masarei, J.R.L. (1983) Relationship of plasma HDL cholesterol to testosterone, estradiol and sex hormone binding globulin levels in men and women. Metabolism, 32, 428-431.
37. Sherwin, B.B. (1988) Affective changes with oestrogen and androgen replacement therapy in surgically menopausal women. Journal of Affective Disorders, 14, 177-187.
38. Sherwin, B.B. & Gelfand, M.M. (1985) Sex steroids and affect in the surgical menopause. A double blind crossover study. Psychoneuroendocrinology, 10, 325-335.
39. Sherwin, B.B., Gelfand, M.M., Schucher, R. & Gabor, J. (1987) Postmenopausal oestrogen and androgen replacement and lipoprotein lipid concentrations. American Journal of Obstetrics and Gynecology, 156, 414-419.
40. Stampfer, M.J., Willett, W.C., Colditz, G.A., Rosner, B., Speizer, F.E. & Hennekens, C.H. (1985) A prospective study of postmenopausal oestrogen therapy in coronary heart disease. New England Journal of Medicine, 313, 1044.
41. Stevenson, J.C., Cook, D. & Godsland, I.F. (1993) Influence of age and menopause on serum lipids and lipoproteins in healthy women. Atherosclerosis, 98, 83-90.
42. Stokke, K.T. & Norum, K.R. (1971) Determination of lecithin cholesterol acyltransferase in human blood plasma. Scandinavian Journal of Clinical Investigation, 27, 21-27.
43. Thompson, P.D., Cullinane, E.M., Sady, S.P., Chenevert, C., Saritelli, A.L., Sady, M.A. & Herbert, P.W. (1989) Contrasting effects of testosterone and stanazolol on serum lipoproteins. Journal of the American Medical Association, 261, 1165-1168.
44. Trinder, P. & Webster, D. (1984) Determination of HDL cholesterol using 2,4,6-tribromo-3-hydroxybenzoic acid with commercial CHOD-PAP reagent. Annals of Clinical Biochemistry 21, 430-433.
45. Watts, N.B., Notelovitz, M., & Timmons, M.C., (1995) Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptons and lipid-lipoprotein profiles in surgical menopausal women. Obstetrics and Gynecology, 85, 529-537.
46. Vermeulen, A. (1976) The hormonal activity of the postmenopausal ovary. Journal of Clinical Endocrinology and Metabolism, 42, 247-252.
47. Wild, R.A., Applebown-Bowden, D., Demers, L.M., Hazzard, W. & Santen, W.J. (1990) Lipoprotein lipids in women with androgen excess. Independent associations with increased insulin and androgen. Clinical Chemistry, 36, 283-289.
48. Yen, S.S.C. (1980) The polycystic ovary syndrome. Clinical Endocrinology, 12, 177-208.